The Medacta International SMS Post-Marketing Surveillance Study
The Medacta SMS Femoral Stem Component. A Multi-National, Multi-Centre, Clinical Surveillance Study
Sponsor: Medacta International SA
This observational or N/A phase trial investigates Arthrosis and Avascular Necrosis of the Femoral Head and is currently actively recruiting participants. Medacta International SA leads this study, which shows 13 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Oct 2025 — Present [monthly]
Recruiting
-
Sep 2025 — Oct 2025 [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Nov 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Sep 2022 — Nov 2023 [monthly]
Recruiting
-
Sep 2021 — Sep 2022 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Oct 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2018 — Oct 2020 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Oct 2017 [monthly]
Recruiting NA
First recorded
Jul 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medacta International SA
For direct contact, visit the study record on ClinicalTrials.gov .